These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 15368324

  • 1. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M.
    Cancer; 2004 Sep 15; 101(6):1364-74. PubMed ID: 15368324
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Sep 15; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
    Eur J Surg Oncol; 2007 Apr 15; 33(3):294-300. PubMed ID: 17129704
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M.
    J Clin Oncol; 2006 Jan 10; 24(2):228-40. PubMed ID: 16344322
    [Abstract] [Full Text] [Related]

  • 7. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 10; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K, Morita T, Tokue A.
    Int J Urol; 2005 Feb 10; 12(2):152-8. PubMed ID: 15733109
    [Abstract] [Full Text] [Related]

  • 9. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.
    Pathol Res Pract; 2008 Feb 10; 204(6):379-87. PubMed ID: 18343598
    [Abstract] [Full Text] [Related]

  • 10. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG, Xiang XJ, He YJ.
    Ai Zheng; 2007 Jan 10; 26(1):90-5. PubMed ID: 17222375
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
    Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C.
    Int J Oncol; 2005 Apr 10; 26(4):977-84. PubMed ID: 15753992
    [Abstract] [Full Text] [Related]

  • 12. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
    Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK.
    Clin Cancer Res; 2003 Apr 10; 9(4):1361-9. PubMed ID: 12684405
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov 10; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 10; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, Murray JC.
    Cancer Res; 2002 Mar 15; 62(6):1669-75. PubMed ID: 11912138
    [Abstract] [Full Text] [Related]

  • 16. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
    Tanigaki Y, Nagashima Y, Kitamura Y, Matsuda H, Mikami Y, Tsukuda M.
    Int J Mol Med; 2004 Sep 15; 14(3):389-95. PubMed ID: 15289890
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH.
    Eur Surg Res; 2007 Sep 15; 39(4):229-38. PubMed ID: 17446709
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I, Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A, del Val Toledo Lobo M.
    Cancer; 2009 Apr 15; 115(8):1701-12. PubMed ID: 19197998
    [Abstract] [Full Text] [Related]

  • 19. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [Abstract] [Full Text] [Related]

  • 20. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
    Nowicki M, Ostalska-Nowicka D, Kaczmarek M, Miskowiak B, Witt M.
    Histopathology; 2007 Feb 15; 50(3):358-64. PubMed ID: 17257131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.